.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

P10

Proof of concept study combining Whole-Body hyperthermia with Gemcitabine and Oxaliplatin (GEMOX) in pancreatic cancer patients

Appointment

Date: 27/09/2023

Time: 17:30 – 17:30

Talk time: 0 Min.

Discussion time: 0 Min.

Location / Stream:

Session

Clinical applications & Trial

Topic

Clinical Applications & Trials

Authors

Kris Van den Cruys (Mechelen, BE), Eke van Zwol (Mechelen, BE), Tine Logghe (Mechelen, BE), Dr. Oleg Rudenko (Mechelen, BE), Luigi Brancato (Mechelen, BE), Johan Van den Bossche (Mechelen, BE), John-Paul Bogers (Mechelen, BE; Antwerp, BE)